About FINSNOBIO, LLC
FinsnoBio is a biotechnology company focused on developing precision medicines for neurodegenerative diseases through small molecule therapies targeting validated genetic causes. The company combines industry professionals and academic experts to advance therapeutic potential in this field.
small molecule therapy developmentgenetic target validationprecision medicine researchclinical affairs managementproject managementDMPK (Drug Metabolism and Pharmacokinetics) expertisetoxicology researchchemistry development
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to FINSNOBIO, LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.